Respiratory Distress Syndrome: all 1,619 studies

Page 8 of 17. Open to participants first (319), then studies with results posted, then the rest; newest registration first within each.

• Pulmonary Fibrosis During Severe COVID-19 PneumoniaActive, not recruitingNCT04987528
• Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress SyndromeStatus unknownNCT04984057Not applicable
• Efficacy of Nebulized Lidocaine, Salbutamol, and Beclomethasone Plus Salbutamol in the Covid-19 Patients With ARDS on Non-invasive Ventilation; Randomized Control TrialStatus unknownNCT04979923Phase 1
• Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University HospitalCompletedNCT04979884Phase 3
• Cognitive Functions After COVID-19CompletedNCT04978246
• Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19Status unknownNCT04977960Phase 2
• Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired PneumoniaTerminatedNCT04972318Not applicable
• Booster Dose of COVID-19 Vaccine for Kidney Transplant Recipients Without Adequate Humoral ResponseStatus unknownNCT04961229Phase 4
• Macintosh Versus Macgrath for Laryngoscopy in COVID 19 Hypoxemic ICU PatientsStatus unknownNCT04956913
• Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19Status unknownNCT04954040Phase 2
• Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 PatientsTerminatedNCT04954014Phase 2
• A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care.WithdrawnNCT04953052Phase 2
• A Retrospective Study of COVID-19 TreatmentsCompletedNCT04949230
• The Association Between LPCAT1 Genetic Polymorphism and Stress Biomarkers in Neonatal Respiratory Distress SyndromeStatus unknownNCT04947215
• The Use of Tadalafil in Confirmed COVID-19 Pneumonia.WithdrawnNCT04946162Phase 4
• LISA vs INSURE in Extremely Low Birth Weight Infants. A Manikin StudyCompletedNCT04944108Not applicable
• imPulse™ Una Infrasound-to-ultrasound E-stethoscopeCompletedNCT04941209
• Comparison of ARDS COVID-19 (WHO) vs ARDS Influenza in the ICUCompletedNCT04941092
• The Mechanism of lncRNA NEAT1 in Alleviating Acute Respiratory Distress Syndrome Through miR-27b Regulated Nrf2 PathwayStatus unknownNCT04937855
• Pulmonary Inflammation in COVID-19 ARDSStatus unknownNCT04935450
• Evaluation of Intracranial Pressure During Mechanical Ventilation Recruitment ManeuverCompletedNCT04935008Not applicable
• Cerebral Autoregulation and COVID-19TerminatedNCT04930874Not applicable
• Closed Loop Mechanical Ventilation and ECMOCompletedNCT04925518Not applicable
• A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)TerminatedNCT04922957Phase 2
• nHFOV Versus Invasive Conventional Ventilation for Preterm Neonates With Respiratory Distress SyndromeWithdrawnNCT04914715Not applicable
• Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress SyndromeWithdrawnNCT04909879Phase 2
• Treatment of ARDS With Sivelestat SodiumCompletedNCT04909697Phase 4
• Cytokine Hemoadsorption in ECMO PatientsCompletedNCT04901338
• Perceptions and Representations of Vaccination Against COVID-19CompletedNCT04896957
• Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP)CompletedNCT04896866Not applicable
• Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®Active, not recruitingNCT04896853Phase 1
• Flow-controlled Ventilation (FCV) in Moderate Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19CompletedNCT04894214
• Impact of Aerosol Box Use on Healthcare Provider ContaminationCompletedNCT04880668Not applicable
• The ECOVITA Study - Validation of LUS Score in SARS-CoV-2 Disease, i.e COVID-19Status unknownNCT04871685
• Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical TrialCompletedNCT04865107Phase 2
• Ultrasound Grayscale Analysis in ARDS covid19CompletedNCT04863534
• Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study.Status unknownNCT04860687
• Cerebral Bleeding in COVID-19 ARDS Patients on Veno-venous ECMOStatus unknownNCT04853953
• Exogenous Surfactant Through Nebulizer Mask on Clinical Outcomes in Covid-19 PatientsStatus unknownNCT04847375Not applicable
• Phrenic Nerve Stimulation-Induced Lung ReAeration TrialCompletedNCT04844892Not applicable
• Efficacy of FES Cycling After a Severe Form of COVID-19CompletedNCT04841746Not applicable
• Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant BacteriaStatus unknownNCT04839653Not applicable
• DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 PneumoniaStatus unknownNCT04836780Phase 3
• Acute and Chronic Pulmonary and Renal Complications Following Contracting Severe Respiratory Distress Syndrome Coronavirus-19Status unknownNCT04827017
• Prone Position Improves End-Expiratory Lung Volumes in COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04818164
• Dexamethasone Before Elective Cesarean Section at Term in Reducing Neonatal Respiratory Distress SyndromeStatus unknownNCT04816097Phase 4
• Clinical Features of COVID-19 PatientsCompletedNCT04815304
• Prospective Electroencephalography Evaluation of Sedation in COVID-19CompletedNCT04815109
• The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19Status unknownNCT04798716Phase 1/2
• Intravenous Imatinib in Mechanically Ventilated COVID-19 PatientsTerminatedNCT04794088Phase 2
• CPAP Or Nasal Cannula Oxygen for Preterm Infants: A Randomized Controlled TrialCompletedNCT04792099Not applicable
• Risk Factors for COVID-19 MortalityTerminatedNCT04786808
• The Value of Rapid Shallow Breathing Indeks in Predicting Non-invasive MechanicalCompletedNCT04780503
• Efficacy of Misoprostol in Prevention of Neonatal Respiratory Morbidity in Parturient at Early Term Elective Caesarian SectionStatus unknownNCT04780412Phase 3
• Large Scale ICU Data Sharing for 1000 Critically Ill Patients With Severe Acute Respiratory Distress Syndrome Coronavirus (SARS.COV19) in Three Distinct Isolation CentersCompletedNCT04779268
• Driving Pressure as a Predictor of Mortality in Acute Respiratory Distress Syndrome PatientsStatus unknownNCT04778228
• Potential for Inhaled Nitric Oxide and Ventilation-Perfusion Mismatch by Electrical Impedance Tomography in the ARDS Patients With Lung RecruitmentStatus unknownNCT04776408Not applicable
• Surfactant Replacement Guided by Early Lung Ultrasound Score in Preterm Newborns With Respiratory Distress SyndromeCompletedNCT04775459
• Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19Status unknownNCT04760821Phase 2
• Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 InfectionsCompletedNCT04751643Not applicable
• Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19CompletedNCT04745442Phase 2
• Identification and Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning PathwayActive, not recruitingNCT04744298Not applicable
• Roflumilast as add-on Therapy in Early Cases of ARDSCompletedNCT04744090Phase 2
• Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress SyndromeWithdrawnNCT04737161Phase 1
• Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory FailureCompletedNCT04733105
• Associations Between COVID-19 ARDS Treatment, Clinical Trajectories and Liberation From Mechanical Ventilator - an Analysis of the NorthCARDS DatasetCompletedNCT04729075
• Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress SyndromeWithdrawnNCT04725110Phase 2
• Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress SyndromeCompletedNCT04725084
• Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19CompletedNCT04719182
• LISA in the Delivery Room for Extremely Preterm InfantsCompletedNCT04715373Not applicable
• Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma TherapyStatus unknownNCT04715360Phase 1/2
• Comparison of High Flow Nasal Cannula (HFNC), Face-mask Non-Invasive Ventilation (NIV) & Helmet NIV in COVID-19 ARDS PatientsTerminatedNCT04715243Not applicable
• High-Dose Vitamin C Treatment in Critically Ill COVID-19 PatientsCompletedNCT04710329
• Tolerability and Efficacy of RJX in Patients With COVID-19Status unknownNCT04708340Phase 1/2
• The Effect of Preemptive APRV on Patients With High Risk for ARDSCompletedNCT04699513Not applicable
• Comparison of Efficacy of Less Invasive Surfactant Treatment Under Nasal CPAP and Nasal IPPVCompletedNCT04698473Not applicable
• Plasma Biomarkers of Cardiopulmonary Bypass Induced Acute Respiratory Distress Syndrome (CPB-ARDS)CompletedNCT04696172
• The Acute Respiratory Intervention StudiEs in Africa (ARISE-AFRICA) StudyCompletedNCT04693403Not applicable
• Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 PatientsStatus unknownNCT04692129
• Effect of Chest Physiotherapy on the Development of Preterm Infants.CompletedNCT04689386Not applicable
• Empirical Steroids and/or Antifungals in Immunocompromised Patients With Acute Respiratory Failure From Undetermined Etiology: a Multicenter Double-blind Randomized Controlled TrialStatus unknownNCT04680884Phase 3
• Pathological Findings of Fatal COVID-19CompletedNCT04675281
• Biomarkers, Genomics, Physiology in Critically Ill and ECMO PatientsStatus unknownNCT04669444Not applicable
• Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndromeCompletedNCT04667923
• Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study PlatformCompletedNCT04663776
• Fenofibrate for Patients With COVID-19 Requiring HospitalizationStatus unknownNCT04661930Phase 3
• Lung Ultrasound Score and Pediatric Intensive Care Outcomes (LUS-PICO)CompletedNCT04660448
• RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot StudyStatus unknownNCT04659460Not applicable
• Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19CompletedNCT04659109Phase 2
• MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 PatientsStatus unknownNCT04646603Phase 2
• Impact of Decreasing Respiratory Rate on Lung Injury Biomarkers in ARDS PatientsCompletedNCT04641897Not applicable
• Effects of Extravascular Lung Water on Prone Position Efficacy in Patients With ARDSStatus unknownNCT04635267
• Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)Active, not recruitingNCT04629105Phase 1
• Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress SyndromeCompletedNCT04625738Phase 2
• Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19CompletedNCT04619368
• Role of Lung Ultrasonography in Prediction of the Seveity and the Need for Surfactant Administration in Neonates With Respiratory Distress SyndromeStatus unknownNCT04618627
• SILtuximab in Viral ARds (SILVAR) StudyTerminatedNCT04616586Phase 3
• Diaphragm Dysfunction in ARDS Patients With V-V ECMOTerminatedNCT04613752Not applicable
• Assessing the Role of Inclined Positioning in Acute Respiratory Distress Syndrome Patients RecoveryCompletedNCT04612608Not applicable
• Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)TerminatedNCT04609943Phase 1

← Respiratory Distress Syndrome overview